Keryx Biopharmaceuticals Inc

CIK 1114220 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Keryx Biopharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Jun 26, 2020CT ORDER9999999997-20-003782
Dec 26, 201815-12G0001193125-18-357359
Dec 21, 2018EFFECT9999999995-18-003191
Dec 21, 2018EFFECT9999999995-18-003190
Dec 21, 2018EFFECT9999999995-18-003188
Dec 21, 2018EFFECT9999999995-18-003189
Dec 21, 2018EFFECT9999999995-18-003198
Dec 21, 2018EFFECT9999999995-18-003192
Dec 21, 2018EFFECT9999999995-18-003196
Dec 21, 2018EFFECT9999999995-18-003193
Dec 21, 2018EFFECT9999999995-18-003194
Dec 21, 2018EFFECT9999999995-18-003195
Dec 13, 2018POS AM0001193125-18-348302
Dec 13, 201840000899243-18-030876
Dec 13, 2018POS AM0001193125-18-348303
Dec 13, 2018SC 13D/A0001567619-18-007895
Dec 13, 201840000899243-18-030881
Dec 13, 2018S-8 POS0001193125-18-348256
Dec 13, 201840000899243-18-030877
Dec 13, 201840000899243-18-030894
Dec 13, 2018POS462B0001193125-18-348355
Dec 13, 2018POS AM0001193125-18-348301
Dec 13, 2018POS AM0001193125-18-348313
Dec 13, 2018S-8 POS0001193125-18-348259
Dec 13, 2018POSASR0001193125-18-348346